SentiAR, Inc. is a pioneering company in the healthcare technology sector, specializing in the development of a 3D augmented reality platform designed for cardiac interventional procedures. The platform provides real-time holographic visualization of the patient's anatomy, allowing clinicians to interact with the holograms through a headset. This technology converts CT, MRI, and real-time mapping catheter location outputs into a hologram within the clinician's field of view, enhancing the accuracy and speed of procedures. SentiAR primarily serves healthcare providers, particularly those in interventional cardiology, offering a transformative tool that improves both patient and clinician experiences. The company operates in the medical technology market and follows a B2B (business-to-business) model, generating revenue through the sale and licensing of its platform to hospitals and medical institutions. The platform is currently under development for eventual FDA submission, ensuring it meets stringent regulatory standards.

Keywords: 3D augmented reality, cardiac procedures, holographic visualization, healthcare technology, real-time mapping, clinician tools, interventional cardiology, medical innovation, FDA submission, B2B model.